Living Carbon

Living Carbon's genetically enhanced trees gain widespread adoption, driven by further major corporate partnerships (like Microsoft) and favorable carbon credit market regulations that reward high-quality, verifiable nature-based solutions. The company successfully scales its planting operations and expands its product offerings (e.g., metal-accumulating trees), pushing revenue to $100M+ by 2028 and justifying a $720M+ valuation (4x current estimated valuation) as it approaches a Series C or D round.

Living Carbon continues to execute on its current strategy, securing additional medium-sized partnerships and expanding its reforestation projects. Revenue grows steadily to ~$30M-$40M by 2028, but scaling challenges and moderate competition limit rapid valuation expansion. The company raises a Series B round at a valuation of $270M (1.5x current estimated valuation), reflecting solid progress but also the capital-intensive nature of the business.

Regulatory hurdles related to genetically modified organisms (GMOs) or challenges in verifying long-term carbon storage slow adoption. Larger incumbents or direct air capture technologies gain significant market share, or the voluntary carbon credit market faces further integrity issues, suppressing demand and pricing for nature-based solutions. Living Carbon struggles to raise its next funding round, leading to a down round or a distressed acquisition at a valuation of $36M or less, severely impairing or wiping out common stock value due to liquidation preferences.